MyChesCo on MSN41m
iECURE Highlights Promising Results from OTC-HOPE Study at 2025 ACMG Genetics MeetingPHILADELPHIA, PA — iECURE, Inc. recently unveiled encouraging early data from its ongoing OTC-HOPE Phase 1/2 study at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback